UBS Group’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.25M Buy
431,653
+19,138
+5% +$342K ﹤0.01% 3685
2025
Q4
$6.61M Buy
412,515
+102,151
+33% +$1.52M ﹤0.01% 3737
2025
Q3
$3.84M Sell
310,364
-32,507
-9% -$381K ﹤0.01% 4308
2025
Q2
$3.95M Sell
342,871
-33,973
-9% -$403K ﹤0.01% 4118
2025
Q1
$5.65M Sell
376,844
-248
-0.1% -$4.15K ﹤0.01% 3668
2024
Q4
$6.53M Buy
377,092
+349,888
+1,286% +$6.75M ﹤0.01% 3527
2024
Q3
$504K Buy
27,204
+12,356
+83% +$248K ﹤0.01% 5216
2024
Q2
$301K Sell
14,848
-12,964
-47% -$229K ﹤0.01% 5393
2024
Q1
$475K Buy
27,812
+2,927
+12% +$46K ﹤0.01% 5247
2023
Q4
$439K Buy
24,885
+23,299
+1,469% +$469K ﹤0.01% 5200
2023
Q3
$38.1K Sell
1,586
-32,551
-95% -$799K ﹤0.01% 6467
2023
Q2
$794K Buy
34,137
+23,136
+210% +$523K ﹤0.01% 4441
2023
Q1
$243K Sell
11,001
-3,030
-22% -$70.9K ﹤0.01% 5243
2022
Q4
$284K Buy
14,031
+10,831
+338% +$210K ﹤0.01% 5172
2022
Q3
$43K Buy
3,200
+2,022
+172% +$34.1K ﹤0.01% 6494
2022
Q2
$23K Sell
1,178
-15,007
-93% -$399K ﹤0.01% 6692
2022
Q1
$512K Buy
16,185
+6,855
+73% +$192K ﹤0.01% 4670
2021
Q4
$208K Sell
9,330
-4,305
-32% -$112K ﹤0.01% 5649
2021
Q3
$378K Sell
13,635
-18,322
-57% -$558K ﹤0.01% 4901
2021
Q2
$1.25M Buy
31,957
+7,873
+33% +$282K ﹤0.01% 3990
2021
Q1
$693K Buy
24,084
+8,784
+57% +$300K ﹤0.01% 4595
2020
Q4
$406K Buy
15,300
+14,043
+1,117% +$287K ﹤0.01% 4767
2020
Q3
$19K Buy
1,257
+89
+8% +$1.87K ﹤0.01% 6340
2020
Q2
$24K Sell
1,168
-1,177
-50% -$21.1K ﹤0.01% 6424
2020
Q1
$24K Sell
2,345
-28,463
-92% -$796K ﹤0.01% 6368
2019
Q4
$1.16M Buy
30,808
+25,921
+530% +$1.16M ﹤0.01% 4060
2019
Q3
$228K Sell
4,887
-1,855
-28% -$86.2K ﹤0.01% 5148
2019
Q2
$352K Sell
6,742
-9,694
-59% -$569K ﹤0.01% 4536
2019
Q1
$1.13M Sell
16,436
-141
-0.9% -$9.45K ﹤0.01% 3480
2018
Q4
$989K Buy
16,577
+3,690
+29% +$318K ﹤0.01% 3702
2018
Q3
$1.49M Buy
12,887
+3,782
+42% +$427K ﹤0.01% 3480
2018
Q2
$1.15M Sell
9,105
-9,737
-52% -$1.19M ﹤0.01% 3662
2018
Q1
$2.04M Buy
18,842
+4,629
+33% +$512K ﹤0.01% 3122
2017
Q4
$1.56M Buy
14,213
+2,099
+17% +$210K ﹤0.01% 3409
2017
Q3
$1.2M Sell
12,114
-13,583
-53% -$1.32M ﹤0.01% 3560
2017
Q2
$2.6M Sell
25,697
-9,240
-26% -$996K ﹤0.01% 2760
2017
Q1
$4.04M Buy
34,937
+20,186
+137% +$2.35M ﹤0.01% 2274
2016
Q4
$1.77M Buy
14,751
+2,293
+18% +$254K ﹤0.01% 3023
2016
Q3
$1.4M Sell
12,458
-1,981
-14% -$228K ﹤0.01% 3155
2016
Q2
$1.79M Buy
14,439
+656
+5% +$79.2K ﹤0.01% 2873
2016
Q1
$1.55M Sell
13,783
-4,327
-24% -$450K ﹤0.01% 2892
2015
Q4
$1.97M Sell
18,110
-1,195
-6% -$137K ﹤0.01% 2805
2015
Q3
$1.93M Sell
19,305
-20,611
-52% -$2.24M ﹤0.01% 2778
2015
Q2
$4.55M Buy
39,916
+4,830
+14% +$586K ﹤0.01% 2175
2015
Q1
$3.67M Sell
35,086
-15,914
-31% -$1.7M ﹤0.01% 2354
2014
Q4
$6.14M Buy
+51,000
New +$6.7M 0.01% 1910

Other funds holding CLB